CYCLOPHOSPHAMIDE
Cyphos-500

CYPHOS-500  is indicated for the treatment of various forms of malignancies, including Burkitt’s and other non-Hodgkin’s lymphomas, multiple myeloma, and mycosis fungoides; gestational trophoblastic tumors; malignancies of the brain, breast, endometrium, lung, and ovary; childhood malignancies such as neuroblastoma, retinoblastoma, and Wilms’ tumor; as well as sarcomas and certain leukemias. It is also indicated for the treatment of immune-mediated conditions, including severe rheumatoid arthritis, systemic lupus erythematosus, vasculitis, dermatomyositis, and interstitial lung disease.

Packaging: Single vial
Shelf Life: 24 months
Origin: India
Dosage Form: Powder for Injection